![Doug Onsi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doug Onsi
Directeur Général chez
CYPHERPUNK TECHNOLOGIES INC.
Fortune : 66 269 $ au 30/06/2026
Profil
Doug E.
Onsi is President, CEO, CFO, Secretary & Treasurer at Cypherpunk Technologies, Inc. since 2020.
He is Director at Adheron Therapeutics, Inc. since 2008.
He is Managing Director at HealthCare Ventures LLC since 2007 and at Healthcare Ventures VII LP.
He is Director at Healthcare Pharmaceuticals, Inc. (Utah) since 2010.
He is Managing Director at Healthcare Partners IX LLC.
He is Director at Vaxxas Pty Ltd. since 2011.
He is Managing Director at Healthcare Strategic Partners, LLC.
Formerly, Mr. Onsi was President, Chief Executive Officer & Director at TetraLogic Research & Development Corp.
from 2013 to 2014.
He was Director at Oriel Therapeutics, Inc. in 2010.
He was Director at Sequoia Pharmaceuticals, Inc. He was Independent Director at TetraLogic Pharmaceuticals Corp.
from 2012 to 2016.
He was Director at Sierra Neuropharmaceuticals, Inc. He was Director at Apellis Pharmaceuticals, Inc. in 2013.
He was Director at Apofore Corp.
He was President & Director at Tensha Therapeutics, Inc. in 2011.
He was Director at Anexon, Inc. in 2009.
He was President, Secretary, Treasurer & Director at TetraLogic Research & Development Corp.
He was Director at Potentia Pharmaceuticals, Inc. He was Principal at LeukoSite, Inc. He was Vice President-Campath Product Operations at Genzyme Corp.
in 2007.
He was Chief Financial Officer at Tolerx, Inc. in 2004.
He was Attorney at Bingham Dana LLP.
He was Member of Cornell University Council.
Mr. Onsi completed undergraduate studies at Cornell University in 1990 and graduate studies at The University of Michigan Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 108 282 ( 0,1 % ) | 66 269 $ | 30/06/2026 |
Postes actifs de Doug Onsi
| Sociétés | Poste | Début |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Directeur Général | 01/04/2020 |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01/08/2007 |
Healthcare Ventures VII LP
 Healthcare Ventures VII LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Healthcare Partners IX LLC | Corporate Officer/Principal | - |
Healthcare Pharmaceuticals, Inc. (Utah)
 Healthcare Pharmaceuticals, Inc. (Utah) Pharmaceuticals: MajorHealth Technology Produces, distributes and retails pharmaceutical medicines | Directeur/Membre du Conseil | 01/01/2010 |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur/Membre du Conseil | 01/01/2008 |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Directeur/Membre du Conseil | 01/01/2011 |
Healthcare Strategic Partners, LLC
 Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
Anciens postes connus de Doug Onsi
| Sociétés | Poste | Fin |
|---|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 05/02/2016 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Doug Onsi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Health Technology |
Sequoia Pharmaceuticals, Inc.
 Sequoia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antiviral therapeutics | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and drug delivery technologies | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Sierra Neuropharmaceuticals, Inc.
 Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Apofore Corp.
 Apofore Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for diabetes | Health Technology |
Tensha Therapeutics, Inc.
 Tensha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule bromodomain inhibitors to treat cancer and other serious disorders | Health Technology |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Bingham Dana LLP
 Bingham Dana LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthcare Ventures VII LP
Healthcare Ventures VII LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Anexon, Inc.
 Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Healthcare Pharmaceuticals, Inc. (Utah)
Healthcare Pharmaceuticals, Inc. (Utah) Pharmaceuticals: MajorHealth Technology Produces, distributes and retails pharmaceutical medicines | Health Technology |
Healthcare Partners IX LLC | |
TetraLogic Research & Development Corp.
 TetraLogic Research & Development Corp. BiotechnologyHealth Technology Develops and produces HDAC inhibitors, biological products, and related pharmaceutical compounds for the medical industry | Health Technology |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Health Technology |
Cornell University Council | |
The University of Michigan Law School
 The University of Michigan Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Healthcare Strategic Partners, LLC
Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
